About
Kevin has over 30 years' experience working in the healthcare sector, principally with pharmaceutical, biotechnology and business consultancy companies. He has been involved in the successful divestment and acquisition of many businesses, acting as advisor to major pharmaceutical and biotechnology companies. Successful transactions he led whilst at PharmaVentures included the sale of 2 Sanofi research sites to Covance, divesting Dow Pharmaceuticals API manufacturing division to Dr Reddy's Ltd, the sale of manufacturing businesses from UCB to Aesica, the divestment of Merck's research site in Newhouse, Scotland to BioCity and in 2012 the divestment of Zentiva's (a Sanofi Group Company) Hlohovec plant to Wood Pharma Holding. In the last five years his divestments have resulted in the successful transfer of over 3,700 jobs to new owners and significant value creation for clients. Kevin also has extensive experience in licensing of research compounds, technologies, IP and pharmaceutical
Position in the VCSift Database
- • 4 investors at Results International are tracked.
- • 1 investors hold the Partner, Results Healthcare role in VCSift. Kevin Bottomley is one of them.
- • 8,972 investors are based in London, England, United Kingdom.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- London, UK
Contact Information
Find more investors like Kevin
Search Investors